One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
GEC-ESTRO ACROP recommendations on calibration and traceability of HE HDR-PDR photon-emitting brachytherapy sources at the hospital level
JosePerez-CalatayudabcFacundoBallesterdcÅsaCarlsson TedgrenefgLarry A.DeWerdhPanagiotisPapagiannisiMark J.RivardjFrank-AndréSiebertkJavierVijandedcl
doi : 10.1016/j.radonc.2022.09.012
Volume 176, November 2022, Pages 108-117
Recommendations for radiation therapy in oligometastatic prostate cancer: An ESTRO-ACROP Delphi consensus
ThomasZilliabcVéraneAchardbcAlanDal PradNinaSchmidt-HegemanneBarbara AlicjaJereczek-FossafgAndreaLanciahGianlucaIngrossoiFilippoAlongijkShafakAluwinilStefanoArcangelimPierreBlanchardnoAntonioConde MorenopFelipeCouñagoqrsGillesCréhangetPietDirixuAlfonsoGomez IturriagavMatthiasGuckenbergerwDavidPasquierxy…ClausBelkae
doi : 10.1016/j.radonc.2022.10.005
Volume 176, November 2022, Pages 199-207
Conventionally fractionated radiotherapy versus CyberKnife hypofractionated radiotherapy for painful vertebral haemangiomas – A randomized clinical trial
MarcinMiszczykaAleksandraNapieralskabGrzegorzWoźniakbMałgorzataKraszkiewiczbMichałGolacMichałKalembadGrzegorzGłowackibBartłomiejTomasikeMagdalenaKocot-KępskafLeszekMiszczyka1
doi : 10.1016/j.radonc.2022.09.008
Volume 176, November 2022, Pages 46-52
OPTimizing Irradiation through Molecular Assessment of Lymph node (OPTIMAL): a randomized clinical trial
ManuelAlgaraaElviraRodrÃguezbFrancisco JoséMartÃnez-ArceluscJuanSalinasdXavierSanzaInmaculadaBeatoeAureaMansofAnaSolergJosé ReyesRodrÃguezhAndereFrÃasiAnaCalÃnjGermánJuankPedroMeireleslAmandaFlaquermon behalf of the OPTIMAL investigators
doi : 10.1016/j.radonc.2022.09.006
Volume 176, November 2022, Pages 76-82
A systematic review exploring the role of modern radiation for the treatment of Hereditary or Familial Breast Cancer
VarshuGoelDayanandSharmaAmanSharmaSupriyaMallick
doi : 10.1016/j.radonc.2022.09.007
Volume 176, November 2022, Pages 59-67
Volumetric changes in gray matter after radiotherapy detected with longitudinal magnetic resonance imaging in glioma patients
Hye InLeeaMin KyoungKangbKihwanHwangcChae-YongKimcYu JungKimdKoung JinSuhdByung SeChoieGheeyoungChoefIn AhKimgBum-SupJanga
doi : 10.1016/j.radonc.2022.09.022
Volume 176, November 2022, Pages 157-164
A phase II trial of hypofractionated high-dose proton beam therapy for unresectable liver metastases
KangpyoKimaJeong IlYuaHee ChulParkaGyu SangYooaDo HoonLimaJae MyoungNohaWoo KyoungJeongb
doi : 10.1016/j.radonc.2022.09.003
Volume 176, November 2022, Pages 9-16
Online adaptive radiotherapy of anal cancer: Normal tissue sparing, target propagation methods, and first clinical experience
Lina M.ÅströmabClaus P.BehrensabKatrine SmedegaardStormaPatrikSiboltaEvaSerup-Hansena
doi : 10.1016/j.radonc.2022.09.015
Volume 176, November 2022, Pages 92-98
Every other day stereotactic radiation therapy for the treatment of uveal melanoma decreases toxicity
GozdeYaziciaHayyamKiratlibGokhanOzyigitaSezin YuceSariaAysenurElmalicMelek TugceYilmazaIremKocbOzgeDeliktasdEkimGumelereMustafaCengizaFarukZorlua
doi : 10.1016/j.radonc.2022.09.010
Volume 176, November 2022, Pages 39-45
An online adaptive plan library approach for intensity modulated proton therapy for head and neck cancer
MichelleOudaSebastiaanBreedveldaMartaGiżyńskabMichielKroesenacStefanHutschemaekerscStevenHabrakenabStevenPetitaZoltánPerkódBenHeijmenaMischaHoogemanab
doi : 10.1016/j.radonc.2022.09.011
Volume 176, November 2022, Pages 68-75
Meta-GWAS identifies the heritability of acute radiation-induced toxicities in head and neck cancer
ElnazNaderiabLine M.H.SchackcdCeilidhWelsheAdelene Y.L.SimfgMiguel E.Aguado-BarrerahiTomDuddingjkHollySummersgillLauraMartÃnez-CalvohiEnya H.W.OnggYasminOddingmAnaVarela-PazosnRoel J.H.M.SteenbakkersaAnne P.G.CrijnsaRajeshJenaoMirandaPringjJoeDennispRamónLobato-BustoqJanAlsnerc…Behrooz Z.Alizadehb
doi : 10.1016/j.radonc.2022.09.016
Volume 176, November 2022, Pages 138-148
Larynx cancer survival model developed through open-source federated learning
ChristianRønn HansenabcdGarethPriceeMatthewFieldfNisSarupaRutaZukauskaitebgJørgenJohansengJesper GrauEriksenghiFarhannahAlyfjkAndrewMcPartlineLoisHollowaydfjkDavidThwaitesdCarstenBrinkab
doi : 10.1016/j.radonc.2022.09.023
Volume 176, November 2022, Pages 179-186
Osteoradionecrosis rate in oropharynx cancer treated with dose volume histogram based constraints
Charles T.LeeaSamuelLitwinbChristopher M.K.L.YaocJeffrey C.LiucdJohn A.RidgecThomas J.Gallowaya
doi : 10.1016/j.radonc.2022.10.011
Volume 176, November 2022, Pages 215-221
Post-irradiation endolymphatic hydrops vs. post-irradiation sudden deafness
Chung-TangTienChun-NanChenYi-HoYoung
doi : 10.1016/j.radonc.2022.10.010
Volume 176, November 2022, Pages 222-227
Clinical application of a sub-fractionation workflow for intrafraction re-planning during prostate radiotherapy treatment on a 1.5 Tesla MR-Linac: A practical method to mitigate intrafraction motion
ThomasWilligenburgCornelZachiuGijsbert H.BolEline N.de Groot-van BeugelJan J.W.LagendijkJochem R.N.van der Voort van ZypBas W.RaaymakersJohannes C.J.de Boer
doi : 10.1016/j.radonc.2022.09.004
Volume 176, November 2022, Pages 25-30
Risk of recurrence after chemoradiotherapy identified by multimodal MRI and 18F-FDG-PET/CT in locally advanced cervical cancer
KjerstiSkiparabcTordHomplandaKjersti VassmoLunddAycaLøndalendEirikMalinenefGunnar B.KristensengKristinaLindemannghEsten S.NakkencKjerstiBruheimcHeidiLyngaf
doi : 10.1016/j.radonc.2022.09.002
Volume 176, November 2022, Pages 17-24
The role of multiple anatomical scenarios in plan optimization for carbon ion radiotherapy of pancreatic cancer
SilviaMolinelliaAlessandroVaiaStefaniaRussoaPierreLoapbGiorgiaMeschinicChiaraPaganellicAmeliaBarcelliniaVivianaVitoloaEsterOrlandiaMarioCioccaa
doi : 10.1016/j.radonc.2022.09.005
Volume 176, November 2022, Pages 1-8
A deep learning approach to generate synthetic CT in low field MR-guided radiotherapy for lung cases
JacopoLenkowiczaClaudioVottaabMatteoNardiniaFlaviovincenzoQuarantabFrancescoCatuccibLucaBoldriniaMaricaVagniaSebastianoMennabLorenzoPlacidiaAngelaRomanoaGiudittaChiloiroaMaria AntoniettaGambacortaaGian CarloMattiuccibcLucaIndovinaaVincenzoValentiniacDavideCusumanoab
doi : 10.1016/j.radonc.2022.08.028
Volume 176, November 2022, Pages 31-38
Bayesian methods provide a practical real-world evidence framework for evaluating the impact of changes in radiotherapy
IsabellaFornacon-WoodaHiteshMistryaCorinneJohnson-HartbCorinneFaivre-FinnacJames P.B.O'ConnoradGareth J.Pricea
doi : 10.1016/j.radonc.2022.09.009
Volume 176, November 2022, Pages 53-58
Development and validation of a population-based anatomical colorectal model for radiation dosimetry in late effects studies of survivors of childhood cancer
Constance A.OwensabBastienRigaudcEthan B.LudmirdeAashish C.GuptaabSumanShresthaabArnold C.PaulinodSusan A.SmithaChristine B.PetersoneStephen F.KryabChoonsikLeefTara O.HendersongGregory T.ArmstronghKristy K.BrockacRebecca M.Howellab
doi : 10.1016/j.radonc.2022.08.027
Volume 176, November 2022, Pages 118-126
Predicting necessity of daily online adaptive replanning based on wavelet image features for MRI guided adaptive radiation therapy
Haidy G.NasiefAbdul K.ParchurEenasOmariYingZhangXinfengChenEricPaulsonWilliam A.HallBethEricksonX. AllenLi
doi : 10.1016/j.radonc.2022.10.001
Volume 176, November 2022, Pages 165-171
Automating implant reconstruction in interstitial brachytherapy of the breast: A hybrid approach combining electromagnetic tracking and image segmentation
ChristopherDürrbeckabBirte ChristinaSauerabMichaelLotterabStephanKreppnerabVratislavStrnadabRainerFietkauabChristophBertab
doi : 10.1016/j.radonc.2022.09.019
Volume 176, November 2022, Pages 172-178
The impact of organ motion and the appliance of mitigation strategies on the effectiveness of hypoxia-guided proton therapy for non-small cell lung cancer
AndreasKötheabAntony JohnLomaxabAnna ChiaraGiovannelliabSairosSafaiaNicolaBizzocchiaErikRoelofscAniek J.G.EvencDamien CharlesWeberadeGiovanniFattoria
doi : 10.1016/j.radonc.2022.09.021
Volume 176, November 2022, Pages 208-214
Effect of mechanical forces on cellular response to radiation
JeromeLacombeabFredericZenhausernabc
doi : 10.1016/j.radonc.2022.10.006
Volume 176, November 2022, Pages 187-198
Protocol Letter: A multi-institutional retrospective case-control cohort investigating PREDiction models for mandibular OsteoRadioNecrosis in head and neck cancer (PREDMORN)
LaiaHumbert-VidanabChristian R.HansencClifton D.FullerdStevenPetiteArjenvan der SchaaffLisanne V.van DijkfGerda M.VerduijneHansLangendijkfCarlesMuñoz-MontpletghWilmaHeemsbergeneMaxWitjesfAbdallah S.R.MohameddAbdul A.KhaniJordiMarruecos QuerolhjIreneOliveras CanciojVinodPatelkAndrew P.KinglJørgenJohansenmTeresaGuerrero Urbanon
doi : 10.1016/j.radonc.2022.09.014
Volume 176, November 2022, Pages 99-100
Automated clinical decision support system with deep learning dose prediction and NTCP models to evaluate treatment complications in patients with esophageal cancer
CamilleDraguetabAna M.Barragán-MonteroaMacarena ChocanVeraaMelissaThomasbcPieterPopulairebcGillesDefraenebKarinHaustermansbcJohn A.LeeaEdmondSterpinab
doi : 10.1016/j.radonc.2022.08.031
Volume 176, November 2022, Pages 101-107
Radiotherapy prioritization in 143 national cancer control plans: Correlation with radiotherapy machine availability, geography and income level
Brooke E.WilsonabAndrewOarcDanielleRodindefFreddieBraygJacquesFerlaygAlfredoPolohJosep M.BorrasiJean-MarcBourquejkMonicaMaliklFabioYnoe de MoraescYolandeLievensmLisa M.StevensnEduardoZubizarretahMei LingYapaopq
doi : 10.1016/j.radonc.2022.09.001
Volume 176, November 2022, Pages 83-91
The correlation between pre-treatment symptoms, acute and late toxicity and patient-reported health-related quality of life in non-small cell lung cancer patients: Results of the REQUITE study
Lottevan der WeijstaDavidAzriabPatrickBerkoviccPierreBoisselierbErikBriersdRenéeBultijnckaeJennyChang-ClaudefgAnanyaChoudhuryhGillesDefraeneiSylvianDemontoisbRebecca M.ElliotthDawnEnniskCorinneFaivre-FinnlMarziaFranceschinimTommasoGiandiniaaAlexandraGiraldosSaraGutiérrez-EnrÃqueznCarstenHerskindo…YolandeLievensa
doi : 10.1016/j.radonc.2022.09.020
Volume 176, November 2022, Pages 127-137
Treatment-related pulmonary adverse events induced by chemoradiation and Durvalumab affect survival in locally advanced non-small cell lung cancer
TingXua1LirongWuab1SaumilGandhiaWangJingcQuyhn-NhuNguyenaAileenChenaJoe Y.ChangaRozaNurievadAjaySheshadrieMehmetAltanfPercy P.LeeaSteven H.LinaZhongxingLiaoa
doi : 10.1016/j.radonc.2022.10.002
Volume 176, November 2022, Pages 149-156
Pan-Canadian consensus recommendations for proton beam therapy access in Canada
GunitaMiteraaDerekTsangbBoydMcCurdyfKarenGoddarddAnnieEbachercTimCraigbJonathanGreenlandeStaciKentishaRashmiKoulfNatalieLogiegMélanieMorneauhAndraMorrisoniLarryPanjJasonPantarottokSophieFoxcroftkJonathanSussmanlRobertThompsonmScottTyldesleyd…SamirPatelo
doi : 10.1016/j.radonc.2022.10.004
Volume 176, November 2022, Pages 228-233
